Literature DB >> 8343473

Role of mitomycin C in pterygium surgery.

P S Mahar1, G E Nwokora.   

Abstract

Mitomycin C in the form of eye drops in a concentration of 0.4 mg/ml (0.04%) was used as adjunctive treatment for primary and recurrent pterygium after surgical excision. The study was concurrent in nature and consisted of 32 pterygia in 30 patients and was done over a period of 36 months. The object was to observe the effect of mitomycin C drops on pterygium recurrence after surgical excision. Fifteen eyes of 15 patients were treated with 'bare sclera technique' for pterygium excision. Nine patients showed recurrence occurring within first 6 months of surgery. On the other hand 17 eyes of 15 patients after bare sclera pterygium excision received mitomycin 0.4 mg/ml (0.04%) eye drops four times a day for 2 weeks from first postoperative day. There was no recurrence of pterygium in this group. Follow up time for these cases ranged from 13-19 months.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8343473      PMCID: PMC504556          DOI: 10.1136/bjo.77.7.433

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  12 in total

1.  Triethylene thiophosphoramide in the prevention of pterygium recurrence.

Authors:  C T MEACHAM
Journal:  Am J Ophthalmol       Date:  1962-11       Impact factor: 5.258

2.  Incidence of pterygium recurrence in patients treated with thio-tepa.

Authors:  G A Joselson; P Muller
Journal:  Am J Ophthalmol       Date:  1966-05       Impact factor: 5.258

3.  Conjunctival transplantation.

Authors:  R A Thoft
Journal:  Arch Ophthalmol       Date:  1977-08

4.  Postoperative instillation of low-dose mitomycin C in the treatment of primary pterygium.

Authors:  S Hayasaka; S Noda; Y Yamamoto; T Setogawa
Journal:  Am J Ophthalmol       Date:  1988-12-15       Impact factor: 5.258

5.  Postoperative beta radiation treatment of pterygium.

Authors:  F Bahrassa; R Datta
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-05       Impact factor: 7.038

6.  Postoperative irradiation of pterygia: ten more years of experience.

Authors:  J S Cooper
Journal:  Radiology       Date:  1978-09       Impact factor: 11.105

7.  The use of postoperative beta radiation in the treatment of pterygia.

Authors:  F Alaniz-Camino
Journal:  Ophthalmic Surg       Date:  1982-12

8.  Pterygium excision with or without postoperative irradiation, a double-blind study.

Authors:  R J de Keizer
Journal:  Doc Ophthalmol       Date:  1982-01-29       Impact factor: 2.379

9.  Inhibition of corneal vascularization by triethylene thiophosphoramide (Thio-Tepa).

Authors:  R L ROCK
Journal:  Arch Ophthalmol       Date:  1963-03

10.  Mitomycin eye drops as treatment for pterygium.

Authors:  G Singh; M R Wilson; C S Foster
Journal:  Ophthalmology       Date:  1988-06       Impact factor: 12.079

View more
  26 in total

1.  Comparative study of intraoperative mitomycin C and beta irradiation in pterygium surgery.

Authors:  S Amano; Y Motoyama; T Oshika; S Eguchi; K Eguchi
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Sutureless and Glue-free Versus Sutures for Limbal Conjunctival Autografting in Primary Pterygium Surgery: A Prospective Comparative Study.

Authors:  Ashok Sharma; Hans Raj; Aditi Gupta; Amit Vikram Raina
Journal:  J Clin Diagn Res       Date:  2015-11-01

3.  Temporary amniotic membrane patch for the treatment of primary pterygium: mechanisms of reducing the recurrence rate.

Authors:  Juan Ye; Koung Hoon Kook; Ke Yao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-09-17       Impact factor: 3.117

4.  The study of etiological and demographic characteristics of pterygium recurrence: a consecutive case series study from Pakistan.

Authors:  P Salim Mahar; Nabeel Manzar
Journal:  Int Ophthalmol       Date:  2013-06-18       Impact factor: 2.031

5.  Meta-analysis on the recurrence rates after bare sclera resection with and without mitomycin C use and conjunctival autograft placement in surgery for primary pterygium.

Authors:  J C Sánchez-Thorin; G Rocha; J B Yelin
Journal:  Br J Ophthalmol       Date:  1998-06       Impact factor: 4.638

6.  Long term results of intraoperative mitomycin C in the treatment of recurrent pterygium.

Authors:  L Mastropasqua; P Carpineto; M Ciancaglini; P Enrico Gallenga
Journal:  Br J Ophthalmol       Date:  1996-04       Impact factor: 4.638

7.  Epidemiology and recurrence rate of pterygium post excision in Ghanaians.

Authors:  V A Essuman; C T Ntim-Amponsah; G K Vemuganti; T A Ndanu
Journal:  Ghana Med J       Date:  2014-03

8.  Prospective trial of intraoperative mitomycin C in the treatment of primary pterygium.

Authors:  J Cano-Parra; M Diaz-Llopis; M J Maldonado; E Vila; J L Menezo
Journal:  Br J Ophthalmol       Date:  1995-05       Impact factor: 4.638

9.  Mitomycin C for pterygium: long term evaluation.

Authors:  F Raiskup; A Solomon; D Landau; M Ilsar; J Frucht-Pery
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

Review 10.  Advances in the use of prodrugs for drug delivery to the eye.

Authors:  Pranjal Taskar; Akshaya Tatke; Soumyajit Majumdar
Journal:  Expert Opin Drug Deliv       Date:  2016-07-21       Impact factor: 6.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.